Page last updated: 2024-08-22

iridium and Arteriosclerosis, Coronary

iridium has been researched along with Arteriosclerosis, Coronary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dauler, M; Haldis, TA; Maehara, A; Mehran, R; Myers, P; Peng, Y; Popma Almonacid, A; Price, MJ; Shlofmitz, RA; Spriggs, DJ1
Colombo, A; Di Mario, C; Grube, E; Liistro, F; Montorfano, M; Sgura, FA1

Trials

2 trial(s) available for iridium and Arteriosclerosis, Coronary

ArticleYear
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, 08-01, Volume: 92, Issue:2

    Topics: Aged; Angina, Stable; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Iridium; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States

2018
The lunar stent characteristics and clinical results.
    Herz, 2002, Volume: 27, Issue:6

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Equipment Design; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Iridium; Male; Middle Aged; Prospective Studies; Radiography; Stents

2002